ADMA Biologics
ADMA
ADMA
52 hedge funds and large institutions have $58M invested in ADMA Biologics in 2018 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 12 closing their positions.
Holders
52
Holders Change
-6
Holders Change %
-10.34%
% of All Funds
1.16%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
7
Increased
17
Reduced
18
Closed
12
Calls
$2K
Puts
$2K
Net Calls
–
Net Calls Change
-$5K
Top Buyers
Top Sellers
| 1 |
PVI
1
Pura Vida Investments
New York
|
$89K |
| 2 |
2
Renaissance Technologies
New York
|
$0 |
| 3 |
KC
3
Kepos Capital
New York
|
$0 |
| 4 |
BC
4
Broadfin Capital
New York
|
$10.1M |
| 5 |
5
JPMorgan Chase & Co
New York
|
$72K |
